Compare Abbott India with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs DISHMAN PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA DISHMAN PHARMA ABBOTT INDIA/
DISHMAN PHARMA
 
P/E (TTM) x 59.7 25.1 238.0% View Chart
P/BV x 17.7 3.3 528.7% View Chart
Dividend Yield % 0.4 0.7 58.5%  

Financials

 ABBOTT INDIA   DISHMAN PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
DISHMAN PHARMA
Mar-16
ABBOTT INDIA/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs8,834374 2,359.5%   
Low Rs5,458129 4,233.9%   
Sales per share (Unadj.) Rs1,731.1197.8 875.2%  
Earnings per share (Unadj.) Rs211.921.2 999.3%  
Cash flow per share (Unadj.) Rs219.934.7 633.3%  
Dividends per share (Unadj.) Rs65.002.00 3,250.0%  
Dividend yield (eoy) %0.90.8 114.5%  
Book value per share (Unadj.) Rs945.2179.9 525.4%  
Shares outstanding (eoy) m21.2580.69 26.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.11.3 324.5%   
Avg P/E ratio x33.711.9 284.1%  
P/CF ratio (eoy) x32.57.2 448.4%  
Price / Book Value ratio x7.61.4 540.4%  
Dividend payout %30.79.4 325.2%   
Avg Mkt Cap Rs m151,84820,306 747.8%   
No. of employees `0003.50.8 420.4%   
Total wages/salary Rs m4,3565,355 81.3%   
Avg. sales/employee Rs Th10,555.519,252.7 54.8%   
Avg. wages/employee Rs Th1,249.96,459.5 19.3%   
Avg. net profit/employee Rs Th1,292.22,064.1 62.6%   
INCOME DATA
Net Sales Rs m36,78615,961 230.5%  
Other income Rs m1,133265 426.9%   
Total revenues Rs m37,91916,226 233.7%   
Gross profit Rs m6,0474,103 147.4%  
Depreciation Rs m1691,091 15.5%   
Interest Rs m23944 2.4%   
Profit before tax Rs m6,9892,334 299.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,485624 398.5%   
Profit after tax Rs m4,5031,711 263.2%  
Gross profit margin %16.425.7 63.9%  
Effective tax rate %35.626.7 133.1%   
Net profit margin %12.210.7 114.2%  
BALANCE SHEET DATA
Current assets Rs m27,61011,018 250.6%   
Current liabilities Rs m8,5699,517 90.0%   
Net working cap to sales %51.89.4 550.4%  
Current ratio x3.21.2 278.3%  
Inventory Days Days60110 54.5%  
Debtors Days Days2735 78.6%  
Net fixed assets Rs m1,05716,304 6.5%   
Share capital Rs m213161 131.7%   
"Free" reserves Rs m19,87312,907 154.0%   
Net worth Rs m20,08614,516 138.4%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m29,40929,805 98.7%  
Interest coverage x311.63.5 8,977.3%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.30.5 233.6%   
Return on assets %15.48.9 172.7%  
Return on equity %22.411.8 190.2%  
Return on capital %34.917.5 199.1%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m3694,952 7.5%   
Fx outflow Rs m4,918697 705.9%   
Net fx Rs m-4,5494,255 -106.9%   
CASH FLOW
From Operations Rs m4,9912,786 179.1%  
From Investments Rs m-2,570-1,529 168.1%  
From Financial Activity Rs m-1,428-941 151.7%  
Net Cashflow Rs m993316 313.9%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 3.7 213.5%  
FIIs % 0.1 12.7 0.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 22.1 77.4%  
Shareholders   18,270 46,261 39.5%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   STERLING BIOTECH  PFIZER  ALEMBIC PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

IndiGo March Quarter Results, Falling Gold Prices, and Top Cues in Focus Today(Pre-Open)

Indian share markets ended on a strong note yesterday. Extending gains for the sixth consecutive day, Indian stock markets edged higher on the back of high buying seen in banking and auto sector.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

Why We Picked This Smallcap Stock for a Post Coronavirus World(Profit Hunter)

May 28, 2020

Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Who Will Be Crowned the 'Multibagger Blue Chip' of the Decade?(Profit Hunter)

May 25, 2020

Will the mutlibagger blue chips of the past decade continue to rule the bourses?

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jun 3, 2020 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - TORRENT PHARMA COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS